$381.57
12.573.41%
Últ. Act.: Nov 6, 4:00 PM
The average analyst price target for Bio-Rad Laboratories is $340.50, 10.8% below the current price. Of 4 analysts, 2 rate it Buy and 2 Hold. Targets range from $290 to $440. The latest change came on Nov 5, 2026, when RBC Capital raised its price target on Bio-Rad Laboratories from $390 to $440 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months